window.dataLayer = window.dataLayer || []; function gtag(){dataLayer.push(arguments);} gtag('js', new Date()); gtag('config', 'G-4PR1PSYQLJ'); Skip to content

Welcome to Discover Pharma! Today is : September 18, 2026

  • News
  • Featured News Archives
    • 12 Days of Christmas
    • Women in Pharma
  • About Us
Contact Us

CRO

  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain,Pharmaceuticals and therapeutics

    Onyx Scientific expands material science capabilities as part of 25th anniversary milestone

    Onyx Scientific has expanded its solid form and material science [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Therapeutic Areas

    Veristat names Kim McLean Boericke as CEO to drive next phase of clinical research growtheristat names Kim McLean Boericke as CEO to drive next phase of clinical research growth

    Veristat, a global clinical research organization (CRO) and consultancy specializing [...]

    May 5, 2026
  • Biotech & Pharma Business,Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    OptymEdge appoints senior director to lead global roll-out of ACUVERA platform

    OptymEdge has appointed Amy Del Medico as senior director of [...]

    May 5, 2026
  • Drug Discovery & Development

    Sygnature Discovery upgrades high-throughput chemistry platform following £1 million investment

    Sygnature Discovery has completed a major upgrade of its high-throughput [...]

    May 5, 2026
  • Biotech & Pharma Business,Drug Discovery & Development,Manufacturing & Supply Chain

    Abzena appoints Geoffrey Glass as CEO to drive next growth phase

    Abzena, the integrated CDMO and CRO specializing in complex biologics [...]

    May 5, 2026
  • Clinical & Regulatory,Drug Discovery & Development,Therapeutic Areas

    Cereno taps global CRO for next big step in pulmonary hypertension drug trial

    Selection of CRO marks key milestone in advancing CS1 as [...]

    May 5, 2026
  • Biotech & Pharma Business,Digital & Data,Drug Discovery & Development

    Oxeltis and MFI join forces as $12.8 BN in silico drug discovery market accelerates

    Contract research firm Oxeltis and computational chemistry company Molecular Forecaster [...]

    May 5, 2026
  • Biotech & Pharma Business

    Phastar appoints industry veteran Billy Amzal as head of strategic consulting

    Biostatistics and real-world evidence expert joins global CRO to advance [...]

    May 5, 2026
  • Clinical & Regulatory,Digital & Data,Drug Discovery & Development

    RBQMLive returns in 2025 with agenda on regulation, ROI and AI in clinical trials

    CluePoints releases full speaker lineup for free virtual event focused [...]

    May 5, 2026
  • Uncategorised

    Selvita licenses Medicines Discovery Catapult’s target engagement technology

    Selvita has become the first contract research organisation (CRO) to [...]

    May 29, 2025
Previous123Next

Bringing you the latest industry news and insights every day

Registered Address: Discover Pharma Ltd, 1 Dartmouth Close, Brighton, BN2 4HZ, UK
Company Number: 16239596

  • About Us
  • Contact Us
  • Legal
    • Cookie Policy
    • Privacy Policy
    • Terms & Conditions
  • Author Guidelines
    • Pharmaceutical Author Guidelines
    • Press Release Advice
  • Advertise with Us
  • Media Kit Request

© 2026 Discover Pharma. All rights reserved • Developed by Hairy Goat Design

Page load link

Press “ESC” key to close

main menu
  • Home
  • News
  • About Us
  • Contact
recent posts
  • ENA Respiratory begins Phase 2a dosing of nasal antiviral INNA-051
    Categories: Clinical & Regulatory, Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
  • Circio raises NOK 200M (€18.6M) to advance in vivo CAR-T programme
    Categories: Advanced Therapies, Biotech & Pharma Business, Research & Development
  • AstraZeneca advances oral COPD drug into Phase 2b trial
    Categories: Pharmaceuticals and therapeutics, Research & Development, Therapeutic Areas
get connected
This website uses cookies and third party services. See our Cookie Policy and Privacy Policy pages for details.
OK
Go to Top